Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Liana Adam"'
Autor:
Rachna T. Shroff, J. Morris, Kanwal Pratap Singh Raghav, Scott Kopetz, Liana Adam, Michael J. Overman, David R. Fogelman, J. Wang, Arvind Dasari, Cathy Eng, Eduardo Vilar, Enusha Karunasena, Nilofer S. Azad, R. Pisanic, Robert A. Wolff, Bryan K. Kee
Background Hypermethylation of promoter CpG islands [CpG island methylator phenotype (CIMP)] represents a unique pathway for the development of colorectal cancer (CRC), characterized by lack of chromosomal instability and a low rate of adenomatous po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d27d159bcf45db84d9859599c0cfe769
https://europepmc.org/articles/PMC5834085/
https://europepmc.org/articles/PMC5834085/
Autor:
T. R. Pisanic, Enusha Karunasena, David R. Fogelman, Robert A. Wolff, Scott Kopetz, Jing Wang, Liana Adam, J. Morris, Cathy Eng, Nilofer S. Azad, Eduardo Vilar, Michael J. Overman, Arvind Dasari, Kanwal Pratap Singh Raghav, Bryan K. Kee, Rachna T. Shroff
Publikováno v:
Annals of Oncology. 30:495
Autor:
Lixia Diao, Chang Gong Liu, David A. Jackson, Liana Adam, Alexander Zien, Colin P.N. Dinney, Wang Jing, Jitao D. Zhang, Matthew F. Wszolek
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 31:1701-1708
Bladder cancer (BC) is a burdensome disease with significant morbidity, mortality, and cost. The development of novel plasma-based biomarkers for BC diagnosis and surveillance could significantly improve clinical outcomes and decrease health expendit
Autor:
Mark F. Munsell, Ameeta Arora, Marissa Shrader, David J. McConkey, Liana Adam, Teruo Inamoto, Colin P.N. Dinney, Xifeng Wu, Arlene O. Siefker-Radtke, Gordon A. Brown, Dan Theodorescu, Peter C. Black, Menashe Bar-Eli
Publikováno v:
Clinical Cancer Research. 14:1478-1486
Purpose: Epidermal growth factor receptor (EGFR) is an attractive target for the treatment of urothelial carcinoma, but a clinical response can be expected in only a small proportion of patients. The aim of this study was to define molecular markers
Publikováno v:
Journal of Urology. 176:787-792
We determined the sequence specific efficacy of gefitinib and docetaxel treatment for bladder cancer. This combination was selected because it is currently under study in a phase II clinical trial.In vitro antiproliferative effects of gefitinib, doce
Publikováno v:
Journal of Urology. 187
Autor:
Liana Adam, Michael B. Williams
Publikováno v:
MicroRNAs in Cancer Translational Research ISBN: 9789400702974
Bladder cancer is the fourth most common solid malignancy in men and fifth most common overall with an estimated 70,000 new cases of urothelial carcinoma (UC) and over 14,000 deaths from the disease expected in 2010 in the United States. Although the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::733c88d7c5d35d549e912c14a12c7a23
https://doi.org/10.1007/978-94-007-0298-1_10
https://doi.org/10.1007/978-94-007-0298-1_10
Autor:
Colin P.N. Dinney, Mark B. Fisher, Paul K. Hegarty, David J. McConkey, Ameeta Arora, Liana Adam, Peter C. Black, Teruo Inamoto
Publikováno v:
Journal of Urology. 179:372-372
1080 E-CADHERIN EXPRESSION POTENTIATES ERLOTINIB TREATMENT IN BLADDER CANCER Teruo Inamoto*, Peter C Black, Mark B Fisher, Paul K Hegarty, Ameeta Arora, Liana Adam, David J McConkey, Colin P Dinney. Houston, TX. INTRODUCTION AND OBJECTIVE: Erlotinib
Publikováno v:
European Journal of Cancer Supplements. 4:146
Autor:
P. Nicola, Peter C. Black, Colin P.N. Dinney, Gordon A. Brown, Menashe Bar-Eli, Mark F. Munsell, Wassim Kassouf, David J. McConkey, Liana Adam
Publikováno v:
European Journal of Cancer Supplements. 4:64